Cancer Stem Cells in Pheochromocytoma and Paraganglioma

Cancer Stem Cells in Pheochromocytoma and Paraganglioma

Pheochromocytoma (PCC) and paraganglioma (PGL) are rare neuroendocrine tumors associated with high cardiovascular morbidity and variable risk of malignancy. The current therapy of choice is surgical resection. Nevertheless, PCCs/PGLs are associated with a lifelong risk of tumor persistence or recurr...

Full description

Bibliographic Details
Main Authors: Laura D. Scriba, Stefan R. Bornstein, Alice Santambrogio, Gregor Mueller, Angela Huebner, Julia Hauer, Andreas Schedl, Ben Wielockx, Graeme Eisenhofer, Cynthia L. Andoniadou, Charlotte Steenblock
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Endocrinology
Subjects:
cancer stem cells
adrenal
pheochromocytoma
paraganglioma
hypoxia
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2020.00079/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2020.00079/full

Similar Items